Logotype for Holland Colours N.V.

Holland Colours (HOLCO) H2 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Holland Colours N.V.

H2 24/25 earnings summary

5 Jun, 2025

Executive summary

  • Revenue grew 8.7% year-over-year to €112.3 million, driven by volume increases and strategic growth initiatives, despite global economic and political uncertainties.

  • Net result rose to €5.9 million from €5.2 million, with EPS at €6.85 versus €6.02 last year; a final dividend of €6.85 per share is proposed, representing 100% payout.

  • EMEIA and Americas divisions posted revenue growth, while Asia saw a decline due to weaker sales in China and Indonesia, partially offset by gains in other Southeast Asian markets.

Financial highlights

  • Operating result increased to €7.9 million from €7.0 million year-over-year; net margin improved to €55.6 million, with margin as a percentage of revenue at 49.5% versus 47.2%.

  • Operating expenses rose 14.2% to €47.6 million, reflecting higher sales, technology, marketing, and IT costs aligned with the strategic roadmap.

  • Net cash flow was €2.0 million positive, down from €2.8 million, with operating activities generating €7.3 million and investments totaling €2.1 million.

  • EBITDA reached €11.4 million, up from €10.2 million; return on sales was 7.1%, and return on investment improved to 17.1%.

Outlook and guidance

  • Heightened global political and economic uncertainties, including new US import tariffs, are expected to negatively impact the world economy in 2025/2026.

  • Mitigation strategies include alternative sourcing and passing on cost increases; indirect effects on demand remain unpredictable, leading to a cautious outlook.

  • Strategic focus remains on accelerating core business growth and developing innovations in recycling and circularity.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more